BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30127519)

  • 1. The tyrosine phosphorylated pro-survival form of Fas intensifies the EGF-induced signal in colorectal cancer cells through the nuclear EGFR/STAT3-mediated pathway.
    Ta NL; Chakrabandhu K; Huault S; Hueber AO
    Sci Rep; 2018 Aug; 8(1):12424. PubMed ID: 30127519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
    Weng MS; Ho CT; Ho YS; Lin JK
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):107-18. PubMed ID: 17182072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a functional EGF-R/p60c-src/STAT3 pathway in colorectal carcinoma: analysis of its long-term prognostic value.
    Hbibi AT; Lagorce C; Wind P; Spano JP; Des Guetz G; Milano G; Benamouzig R; Rixe O; Morere JF; Breau JL; Martin A; Fagard R
    Cancer Biomark; 2008; 4(2):83-91. PubMed ID: 18503159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperosmolarity and CD95L trigger CD95/EGF receptor association and tyrosine phosphorylation of CD95 as prerequisites for CD95 membrane trafficking and DISC formation.
    Reinehr R; Schliess F; Häussinger D
    FASEB J; 2003 Apr; 17(6):731-3. PubMed ID: 12586732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src‑mediated phosphorylation of EGF receptor tyrosine kinase.
    Kundu J; Choi BY; Jeong CH; Kundu JK; Chun KS
    Oncol Rep; 2014 Aug; 32(2):821-8. PubMed ID: 24890449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
    Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
    Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Evolution-Guided Analysis Reveals a Multi-Signaling Regulation of Fas by Tyrosine Phosphorylation and its Implication in Human Cancers.
    Chakrabandhu K; Huault S; Durivault J; Lang K; Ta Ngoc L; Bole A; Doma E; Dérijard B; Gérard JP; Pierres M; Hueber AO
    PLoS Biol; 2016 Mar; 14(3):e1002401. PubMed ID: 26942442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamin II function is required for EGF-mediated Stat3 activation but not Erk1/2 phosphorylation.
    Luwor RB; Chin X; McGeachie AB; Robinson PJ; Zhu HJ
    Growth Factors; 2012 Aug; 30(4):220-9. PubMed ID: 22574813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3-mediated coincidence detection regulates noncanonical immediate early gene induction.
    Waitkus MS; Chandrasekharan UM; Willard B; Haque SJ; DiCorleto PE
    J Biol Chem; 2013 Apr; 288(17):11988-2003. PubMed ID: 23504318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GH modulates hepatic epidermal growth factor signaling in the mouse.
    González L; Díaz ME; Miquet JG; Sotelo AI; Fernández D; Dominici FP; Bartke A; Turyn D
    J Endocrinol; 2010 Mar; 204(3):299-309. PubMed ID: 20032199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening.
    Cheng CC; Liao PN; Ho AS; Lim KH; Chang J; Su YW; Chen CG; Chiang YW; Yang BL; Lin HC; Chang YC; Chang CC; Chang YF
    J Biomed Sci; 2018 Aug; 25(1):60. PubMed ID: 30068339
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Suradej B; Sookkhee S; Panyakaew J; Mungkornasawakul P; Wikan N; Smith DR; Potikanond S; Nimlamool W
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470515
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes.
    Lo HW; Cao X; Zhu H; Ali-Osman F
    Mol Cancer Res; 2010 Feb; 8(2):232-45. PubMed ID: 20145033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
    Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
    Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docoxahexaenoic Acid Induces Apoptosis of Pancreatic Cancer Cells by Suppressing Activation of STAT3 and NF-κB.
    Park M; Lim JW; Kim H
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.
    Cardoso AP; Pinto ML; Pinto AT; Oliveira MI; Pinto MT; Gonçalves R; Relvas JB; Figueiredo C; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ
    Oncogene; 2014 Apr; 33(16):2123-33. PubMed ID: 23644655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal Growth Factor Induces Proliferation of Hair Follicle-Derived Mesenchymal Stem Cells Through Epidermal Growth Factor Receptor-Mediated Activation of ERK and AKT Signaling Pathways Associated with Upregulation of Cyclin D1 and Downregulation of p16.
    Bai T; Liu F; Zou F; Zhao G; Jiang Y; Liu L; Shi J; Hao D; Zhang Q; Zheng T; Zhang Y; Liu M; Li S; Qi L; Liu JY
    Stem Cells Dev; 2017 Jan; 26(2):113-122. PubMed ID: 27702388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
    Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
    Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.